Literature DB >> 34072900

Time in Range for Closed-Loop Systems versus Standard of Care during Physical Exercise in People with Type 1 Diabetes: A Systematic Review and Meta-Analysis.

Max L Eckstein1, Benjamin Weilguni2, Martin Tauschmann3, Rebecca T Zimmer1, Faisal Aziz2, Harald Sourij2, Othmar Moser1,2.   

Abstract

The aim of this systematic review and meta-analysis was to compare time in range (TIR) (70-180 mg/dL (3.9-10.0 mmol/L)) between fully closed-loop systems (CLS) and standard of care (including hybrid systems) during physical exercise in people with type 1 diabetes (T1D). A systematic literature search was conducted in EMBASE, PubMed, Cochrane Central Register of Controlled Trials, and ISI Web of Science from January 1950 until January 2020. Randomized controlled trials including studies with different CLS were compared against standard of care in people with T1D. The meta-analysis was performed using the random effects model and restricted maximum likelihood estimation method. Six randomized controlled trials involving 153 participants with T1D of all age groups were included. Due to crossover test designs, studies were included repeatedly (a-d) if CLS or physical exercise interventions were different. Applying this methodology increased the comparisons to a total number of 266 participants. TIR was higher with an absolute mean difference (AMD) of 6.18%, 95% CI: 1.99 to 10.38% in favor of CLS. In a subgroup analysis, the AMD was 9.46%, 95% CI: 2.48% to 16.45% in children and adolescents while the AMD for adults was 1.07% 95% CI: -0.81% to 2.96% in favor of CLS. In this systematic review and meta-analysis CLS moderately improved TIR in comparison to standard of care during physical exercise in people with T1D. This effect was particularly pronounced for children and adolescents showing that the use of CLS improved TIR significantly compared to standard of care.

Entities:  

Keywords:  artificial pancreas; exercise; time in range; type 1 diabetes

Year:  2021        PMID: 34072900     DOI: 10.3390/jcm10112445

Source DB:  PubMed          Journal:  J Clin Med        ISSN: 2077-0383            Impact factor:   4.241


  41 in total

1.  Fully Closed-Loop Multiple Model Probabilistic Predictive Controller Artificial Pancreas Performance in Adolescents and Adults in a Supervised Hotel Setting.

Authors:  Gregory P Forlenza; Faye M Cameron; Trang T Ly; David Lam; Daniel P Howsmon; Nihat Baysal; Georgia Kulina; Laurel Messer; Paula Clinton; Camilla Levister; Stephen D Patek; Carol J Levy; R Paul Wadwa; David M Maahs; B Wayne Bequette; Bruce A Buckingham
Journal:  Diabetes Technol Ther       Date:  2018-04-16       Impact factor: 6.118

2.  RoB 2: a revised tool for assessing risk of bias in randomised trials.

Authors:  Jonathan A C Sterne; Jelena Savović; Matthew J Page; Roy G Elbers; Natalie S Blencowe; Isabelle Boutron; Christopher J Cates; Hung-Yuan Cheng; Mark S Corbett; Sandra M Eldridge; Jonathan R Emberson; Miguel A Hernán; Sally Hopewell; Asbjørn Hróbjartsson; Daniela R Junqueira; Peter Jüni; Jamie J Kirkham; Toby Lasserson; Tianjing Li; Alexandra McAleenan; Barnaby C Reeves; Sasha Shepperd; Ian Shrier; Lesley A Stewart; Kate Tilling; Ian R White; Penny F Whiting; Julian P T Higgins
Journal:  BMJ       Date:  2019-08-28

3.  Outpatient overnight glucose control with dual-hormone artificial pancreas, single-hormone artificial pancreas, or conventional insulin pump therapy in children and adolescents with type 1 diabetes: an open-label, randomised controlled trial.

Authors:  Ahmad Haidar; Laurent Legault; Laurence Matteau-Pelletier; Virginie Messier; Maryse Dallaire; Martin Ladouceur; Rémi Rabasa-Lhoret
Journal:  Lancet Diabetes Endocrinol       Date:  2015-06-08       Impact factor: 32.069

4.  Use of insulin pump therapy in the pediatric age-group: consensus statement from the European Society for Paediatric Endocrinology, the Lawson Wilkins Pediatric Endocrine Society, and the International Society for Pediatric and Adolescent Diabetes, endorsed by the American Diabetes Association and the European Association for the Study of Diabetes.

Authors:  Moshe Phillip; Tadej Battelino; Henry Rodriguez; Thomas Danne; Francine Kaufman
Journal:  Diabetes Care       Date:  2007-03-19       Impact factor: 19.112

5.  Fully integrated artificial pancreas in type 1 diabetes: modular closed-loop glucose control maintains near normoglycemia.

Authors:  Marc Breton; Anne Farret; Daniela Bruttomesso; Stacey Anderson; Lalo Magni; Stephen Patek; Chiara Dalla Man; Jerome Place; Susan Demartini; Simone Del Favero; Chiara Toffanin; Colleen Hughes-Karvetski; Eyal Dassau; Howard Zisser; Francis J Doyle; Giuseppe De Nicolao; Angelo Avogaro; Claudio Cobelli; Eric Renard; Boris Kovatchev
Journal:  Diabetes       Date:  2012-06-11       Impact factor: 9.461

6.  Feasibility of automating insulin delivery for the treatment of type 1 diabetes.

Authors:  Garry M Steil; Kerstin Rebrin; Christine Darwin; Farzam Hariri; Mohammed F Saad
Journal:  Diabetes       Date:  2006-12       Impact factor: 9.461

7.  Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas.

Authors:  Stuart A Weinzimer; Garry M Steil; Karena L Swan; Jim Dziura; Natalie Kurtz; William V Tamborlane
Journal:  Diabetes Care       Date:  2008-02-05       Impact factor: 19.112

8.  The Cochrane Collaboration's tool for assessing risk of bias in randomised trials.

Authors:  Julian P T Higgins; Douglas G Altman; Peter C Gøtzsche; Peter Jüni; David Moher; Andrew D Oxman; Jelena Savovic; Kenneth F Schulz; Laura Weeks; Jonathan A C Sterne
Journal:  BMJ       Date:  2011-10-18

9.  Closed-loop glucose control in young people with type 1 diabetes during and after unannounced physical activity: a randomised controlled crossover trial.

Authors:  Klemen Dovc; Maddalena Macedoni; Natasa Bratina; Dusanka Lepej; Revital Nimri; Eran Atlas; Ido Muller; Olga Kordonouri; Torben Biester; Thomas Danne; Moshe Phillip; Tadej Battelino
Journal:  Diabetologia       Date:  2017-08-24       Impact factor: 10.122

10.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.

Authors:  David Moher; Alessandro Liberati; Jennifer Tetzlaff; Douglas G Altman
Journal:  PLoS Med       Date:  2009-07-21       Impact factor: 11.069

View more
  3 in total

Review 1.  Closed-Loop Artificial Pancreas Therapy for Type 1 Diabetes.

Authors:  Keren Zhou; Diana Isaacs
Journal:  Curr Cardiol Rep       Date:  2022-06-21       Impact factor: 3.955

2.  Exercise regulates cardiac metabolism: Sex does matter.

Authors:  Tingting Yang; Meiyu Hu; Michail Spanos; Guoping Li; Stephen C Kolwicz; Junjie Xiao
Journal:  J Sport Health Sci       Date:  2022-06-07       Impact factor: 13.077

3.  Dual-hormone artificial pancreas for glucose control in type 1 diabetes: A meta-analysis.

Authors:  Baoqi Zeng; Hao Jia; Le Gao; Qingqing Yang; Kai Yu; Feng Sun
Journal:  Diabetes Obes Metab       Date:  2022-06-21       Impact factor: 6.408

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.